We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AKAN market cap is 3.07M. The company's latest EPS is USD -1.7997 and P/E is -0.76.
| Quarter End | ||||
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | ||||
| Operating Income | ||||
| Net Income |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41k | 3.87M | 2.16M | 836k |
| Operating Income | -4.26M | -15.72M | -10.05M | -4.89M |
| Net Income | -8.13M | -11.66M | -32.28M | -4.1M |
| Quarter End | ||||
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | ||||
| Total Liabilities | ||||
| Total Equity |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.05M | 39M | 8.84M | 7.91M |
| Total Liabilities | 10.25M | 12.1M | 12.67M | 3.64M |
| Total Equity | -2.2M | 26.9M | -3.83M | 4.28M |
| Market Cap | 3.07M |
| Price to Earnings Ratio | -0.76 |
| Price to Sales Ratio | 3.73 |
| Price to Cash Ratio | 0.81 |
| Price to Book Ratio | 0.73 |
| Dividend Yield | - |
| Shares Outstanding | 2.28M |
| Average Volume (1 week) | 58.07k |
| Average Volume (1 Month) | 74.09k |
| 52 Week Change | -69.73% |
| 52 Week High | 4.8198 |
| 52 Week Low | 0.9301 |
| Spread (Intraday) | 0.07 (4.93%) |
| Company Name | Akanda Corporation |
| Address |
77 king street west suite 400 toronto, ontario M5K 0A1 |
| Website | https://www.akandacorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
